PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 74 filers reported holding PMV PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,333,302 | -5.9% | 542,883 | -4.1% | 0.00% | 0.0% |
| Q2 2023 | $3,542,803 | -14.6% | 565,943 | -35.0% | 0.00% | 0.0% |
| Q1 2023 | $4,150,158 | -42.1% | 870,054 | +5.5% | 0.00% | 0.0% |
| Q4 2022 | $7,173,760 | -44.9% | 824,570 | -24.6% | 0.00% | -66.7% |
| Q3 2022 | $13,008,000 | -19.1% | 1,093,116 | -3.1% | 0.00% | 0.0% |
| Q2 2022 | $16,083,000 | +1098.4% | 1,128,567 | +1650.9% | 0.00% | – |
| Q1 2022 | $1,342,000 | +85.4% | 64,456 | +105.7% | 0.00% | – |
| Q4 2021 | $724,000 | -97.8% | 31,337 | -96.8% | 0.00% | -100.0% |
| Q2 2021 | $33,148,000 | +0.0% | 970,364 | -3.7% | 0.01% | 0.0% |
| Q1 2021 | $33,144,000 | -58.2% | 1,007,723 | -22.8% | 0.01% | -60.0% |
| Q4 2020 | $79,230,000 | +38.7% | 1,305,179 | -20.7% | 0.02% | +25.0% |
| Q3 2020 | $57,139,000 | – | 1,645,822 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 4,179,416 | $257,076,000 | 54.42% |
| INTERWEST VENTURE MANAGEMENT CO | 6,469,911 | $397,964,000 | 49.71% |
| Octagon Capital Advisors LP | 250,000 | $15,378,000 | 5.33% |
| Boxer Capital, LLC | 2,268,236 | $139,519,000 | 4.48% |
| COMMODORE CAPITAL LP | 125,000 | $7,689,000 | 4.18% |
| Orbimed Advisors | 7,330,423 | $450,894,000 | 3.95% |
| Asymmetry Capital Management, L.P. | 96,595 | $5,942,000 | 2.71% |
| Avoro Capital Advisors LLC | 2,350,267 | $130,536,000 | 2.25% |
| RA Capital Management | 1,710,265 | $105,198,000 | 1.47% |
| HighVista Strategies LLC | 22,654 | $1,393,000 | 0.89% |